Biomarkers in Wegener's Granulomatosis and Microscopische polyangiitis

Biomarkers in Wegener's Granulomatosis and Microscopische polyangiitis - Biomarkers in AAV

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON35695

Enrollment

300

Registered

2010-07-08

Start date

2010-07-08

Completion date

Unknown

Last updated

2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

microscopische polyangiitis Wegener's disease

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Caucasian identity, clinical diagnosis of ANCA-associated vasculitis, ANCA antibody positivity currently or in the past

Exclusion criteria

Exclusion criteria: age

Design outcomes

Primary

Measure	Time frame
zie boven	—

Secondary

Measure	Time frame
zie boven	—

Countries

Netherlands

Outcome results